期刊文献+

从全国室间质量评价结果探讨HCV RNA检测中的问题 被引量:1

Analysis of the results of external quality assessment for hepatitis C virus RNA tests
原文传递
导出
摘要 目的评价2012年第一次HCV RNA检测的全国室间质量结果,以分析探讨我国临床实验室HCV RNA检测中存在的问题,为进一步改进和提高实验室检测质量提供依据。方法卫生部临检中心(以下简称“部中心”)2012年共发放5份样本至927家参评实验室,其中1份为阴性,4份为与国际标准物质比对定值的内含HCV RNA相应片段的病毒样颗粒。参评实验室按照规定的时间检测样本,并向部中心回报结果。然后,计算所有参评实验室和各检测试剂(实验室数≥5家)对每份质评样本定性和定量检测的符合率。计算总体参评实验室和不同试剂对阳性样本检测的均值(GM)和标准差(S)。将所有参评实验室和不同试剂检测的GM和靶值比较,绘制相关性曲线。结果参评实验室检测1211、1212、1213、1214号样本定性结果的符合率分别为99.5%(403/405)、98.5%(400/406)、100.0%(405/405)、100.0%(406/406),阴性样本的符合率为99%(401/405);检测1211、1212和1213号样本定量结果的符合率相近,分别为93.8%(549/585)、92.3%(541/586)和94.5%(554/586),HCV RNA浓度最高的1214号样本符合率仅为87.7%(514/586)。试剂A对1214号样本定量符合率仅为67.2%(92/137)。总体参评实验室HCV RNA定量结果GM(1211、1212、1213和1214号样本GM分别为4.63、4.11、5.41和6.23)与靶值(1211、1212、1213和1214号样本靶值对数值分别为4.64、4.16、5.40和6.20)结果非常接近。试剂C、试剂E和试剂G的GM均与靶值不一致,试剂C检测1211、1212、1213和1214号样本的GM依次为4.22、3.56、5.16和5.90,试剂E检测1211、1212、1213和1214号样本的GM依次为4.52、3.78、5.55和6.29,试剂G检测1211、1212、1213和1214号样本的GM依次为4.83、4.36、5.72和6.56。结论临床实验室定性和定量检测HCV RNA的结果较为理想。但在检测试剂和临床实验室检测过程中,仍存在试剂GM与靶值偏差较大、使用同一试剂的不同实验室间结果差异较大、临床实验室检测存在系统和随机误差等问题,此外,检测重复性和试剂质量也有待进一步提高。(中华检验医学杂志,2013,36:271-276) Objective To evaluate the performance of HCV RNA detection in the first EQA program in 2012 and analyze possible problems in clinical laboratories. Methods The panel consisting of L 5 samples was distributed to 927 laboratories. Each panel contains one negative sample and 4 positive samples, which were virus-like particles calibrated by international standard. The percent agreements of all the laboratories for qualitative and quantitative results were calculated. Genomic means (GM) and standard deviations (s) of all laboratories and each reagent were calculated. The overall GM and the GM of each reagent were compared with expected results and correlation curves were calculated. Results The percent agreements of sample 1211,1212,1213,1214 for qualitative results were 99. 5 % (403/405), 98.5 % ( 400/406) , 100. 0% (405/405), 100. 0% (406/406) , respectively. The percent agreement of the negative sample was 99% (401/405). The percent agreements of sample 1211, 1212 and 1213 for quantitive results were similar, whieh were 93.8%-(549/585 ) ,92. 3% (541/586)and 94. 5% (554/586). However, the agreement of sample 1214 was only 87.7% (514/586)and the agreement of sample 1214 for reagent A was 67.2% (92/137). The overall GM agreed with expected results, while GMs of reagent C, E and G deviated from expected results. GMs of sample 1211, 1212, 1213 and 1214 reported by labs using reagent C were 4. 22,3.56,5. 16 and 5.90, respectively. GMs of sample 1211 , 1212, 1213 and 1214 reported by labs using reagent E were 4. 52,3.78,5.55 and 6.29, respectively. GMs of sample 1211, 1212, 1213 and 1214 reported by labs using reagent G were 4. 83,4. 36,5.72 and 6. 56, respectively. Conclusions The overall results of HCV RNA qualitative and quantitative detection are satisfactory. However, some problems still exist, such as deviation of GM of some reagents, the interassay variability, systematic deviation and accidental deviation, which show that the quality of reagents should be improved. ( Chin J Lab Med, 2013,36:271-276)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2013年第3期271-276,共6页 Chinese Journal of Laboratory Medicine
基金 国家高技术研展发展计划(863计划)资助项目(2011AA02A116)
关键词 肝炎病毒属 RNA 病毒 质量控制 Hepacivirus RNA, viral Quality control
  • 相关文献

参考文献4

二级参考文献16

  • 1王露楠,李金明,邓巍,王忠芳.乙型肝炎病毒DNA定值冻干血清用于荧光定量聚合酶链反应测定的研究[J].中华检验医学杂志,2004,27(8):523-525. 被引量:9
  • 2李金明,王忠芳,王露楠,彭建明,邓巍.T载体克隆在病毒样颗粒表达载体构建中的应用[J].中华检验医学杂志,2004,27(11):786-788. 被引量:12
  • 3王露楠,吴健民,李金明,邓巍,王忠芳,申子瑜,陈文祥.丙型肝炎病毒核酸检测的国家标准物质的研制[J].中华检验医学杂志,2006,29(4):354-357. 被引量:40
  • 4WANG Lu-nan,WU Jian-min,DENG Wei,SHEN Zi-yu,CHEN Wen-xiang,LI Jin-ming.Lyophilized standards for the calibration of real time PCR assay for hepatitis C virus RNA[J].Chinese Medical Journal,2006(22):1910-1914. 被引量:3
  • 5Saldanha J,Lelie N,Heath A.Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA.Vox Sanguinis,1999,76:149-158.
  • 6Saldanha J,Heath A,Aberham C,et al.World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays.Vox Sang,2005,88:202-204.
  • 7Saldanha J,Heath A,Lelie N,et al.Calibration of HCV Working reagents for NAT Assays against the HCV International Standard.Vox Sang,2000,78:217-224.
  • 8Jorgen PA,Neuwald PD.Standardized hepatitis C virus RNA panels for nucleic acid testing assays.J Clin Virol,2001,20:35-40.
  • 9Saldanha J,Heath A,Collaborative Study Group.Collaborative study to calibrate hepatitis C virus genotypes 2-6 against the HCV International Standard,96/790 (genotype 1).Vox Sang,2003,84:20-27.
  • 10Saldanha J.Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products.J Clin Virol,2001,20:7-13.

共引文献135

同被引文献9

  • 1张鸿,苏兴利,刘晓兰,张树林,Arthur Love.重组免疫印迹实验在HCV感染诊断中的价值[J].陕西医学杂志,2007,36(3):314-315. 被引量:1
  • 2DUFOUR DR,TALASTAS M,FERNANDEZ MD,et al. Low - posi-tive anti - hepatitis C virus enzyme immunoassay results: an importantp redictor of low likelihood of hepatitis C infection[J]. Clin Chem2013,49( 3) : 479 - 486.
  • 3SAKUGAWA H,NAKASONE H,NAKAYOSHI T,et al. High propor-tion of false positive reactions among donors with anti - HCV antibodiesin a low prevalence area[J]. J Med Virol,2009,46( 4) : 334 - 338.
  • 4CDC. Recommendations for preventing transmission of infections a-mong chronic hemodialysis patients [J]. MMWR Recomm Rep,2012,50( RR - 5) : 1 - 43.
  • 5LARGHI A,ZUIN M,CROSIGNANI A,et al. Outcome of an out-break of acute hepatitis C among healthy volunteers participating inpharmacokinetics studies[J]. Hepatology,2013,36 ( 4Pt1 ) : 993- 1000.
  • 6ALTER HJ,SEEFF LB. Recovery,persistence,and sequelae inhepatitis C virus infection: a perspective on longterm outcome[J].Semin Liver Dis,2010,20( 1) : 17 - 35.
  • 7WILLIAMS IT,GRETCH D,FLEENOR M,et al. Hepatitis C vi-rus RNA concentration and chronic hepatitis in a cohort of patientsfollowed after developing acute hepatitis C[M]/ / MARGOLIS HS,ALTER MJ,LIANG TJ,et al. Viral hepatitis and liver disease. At-lanta,GA: International Medical Press,2012: 341 - 344.
  • 8THOMAS DL,ASTEMBORSKI J,RAI RM,et al. The natural his-tory of hepatitis C virus infection: host,viral,and environmentalfactors[J]. JAMA,2010,284( 4) : 450 - 456.
  • 9ALTER MJ,MARGOLIS HS,KRAWCZYNSKI K,et al. Naturalhistory of community acquired hepatitis C in the United States[J].N Engl J Med,2012,327( 4) : 1899 - 1905.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部